Found: 57
Select item for more details and to access through your institution.
Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study.
- Published in:
- BJU International, 2010, v. 106, n. 7, p. 974, doi. 10.1111/j.1464-410X.2010.09296.x
- By:
- Publication type:
- Article
Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer †.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 651, doi. 10.3390/pharmaceutics15020651
- By:
- Publication type:
- Article
VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric Study.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 414, doi. 10.3390/ph13110414
- By:
- Publication type:
- Article
Very Long-Term Complete Remission Can Be Achieved in Men With High-Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 5, p. 615e1, doi. 10.1016/j.clgc.2023.05.003
- By:
- Publication type:
- Article
TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 6, p. 501, doi. 10.1016/j.clgc.2021.08.008
- By:
- Publication type:
- Article
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 1, p. 191, doi. 10.1007/s10549-021-06382-6
- By:
- Publication type:
- Article
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 2, p. 397, doi. 10.1007/s10549-018-5017-2
- By:
- Publication type:
- Article
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 2, p. 356, doi. 10.1245/s10434-018-6831-9
- By:
- Publication type:
- Article
Chimiothérapie ciblée du cancer du sein basée sur une analyse génomique de la tumeur: Adhésion des patientes, craintes et malentendus.
- Published in:
- Médecine Sciences, 2012, v. 38, n. S37, p. 24, doi. 10.1051/medsci/201228s107
- By:
- Publication type:
- Article
DPD status and fluoropyrimidines-based treatment: high activity matters too.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42744-y
- By:
- Publication type:
- Article
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42744-y
- By:
- Publication type:
- Article
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221077082
- By:
- Publication type:
- Article
Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359211070362
- By:
- Publication type:
- Article
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987657
- By:
- Publication type:
- Article
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987657
- By:
- Publication type:
- Article
Management and outcome of male metastatic breast cancer in the national multicenter observational research program Epidemiological Strategy and Medical Economics (ESME).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920980548
- By:
- Publication type:
- Article
Accelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy.
- Published in:
- Radiation Oncology, 2014, v. 9, n. 1, p. 1, doi. 10.1186/1748-717X-9-115
- By:
- Publication type:
- Article
Accelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Age-related difference in tamoxifen disposition.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 4, p. 401, doi. 10.1016/S0009-9236(96)90108-3
- By:
- Publication type:
- Article
Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. e2231170, doi. 10.1001/jamanetworkopen.2022.31170
- By:
- Publication type:
- Article
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00319-4
- By:
- Publication type:
- Article
Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.
- Published in:
- NPJ Breast Cancer, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41523-017-0005-y
- By:
- Publication type:
- Article
Metabolomic Signatures of Scarff–Bloom–Richardson (SBR) Grade in Non-Metastatic Breast Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 1941, doi. 10.3390/cancers15071941
- By:
- Publication type:
- Article
Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1191, doi. 10.3390/cancers15041191
- By:
- Publication type:
- Article
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2596, doi. 10.3390/cancers14112596
- By:
- Publication type:
- Article
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01416-5
- By:
- Publication type:
- Article
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01416-5
- By:
- Publication type:
- Article
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 121, n. 1, p. 121, doi. 10.1007/s10549-010-0788-0
- By:
- Publication type:
- Article
Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2343910, doi. 10.1001/jamanetworkopen.2023.43910
- By:
- Publication type:
- Article
Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 12, p. e2247154, doi. 10.1001/jamanetworkopen.2022.47154
- By:
- Publication type:
- Article
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real‐world database.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 5, p. 921, doi. 10.1002/ijc.34304
- By:
- Publication type:
- Article
Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 4, p. 738, doi. 10.1002/cncr.22070
- By:
- Publication type:
- Article
Optimizing drug development in oncology by clinical trial simulation: Why and how?
- Published in:
- Briefings in Bioinformatics, 2018, v. 19, n. 6, p. 1203, doi. 10.1093/bib/bbx055
- By:
- Publication type:
- Article
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 6, p. 489, doi. 10.1007/s00280-004-0762-9
- By:
- Publication type:
- Article
The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 6, p. 459, doi. 10.1007/s00280-002-0519-2
- By:
- Publication type:
- Article
Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-67431-6
- By:
- Publication type:
- Article
Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 12, p. 3359, doi. 10.1002/ijc.32402
- By:
- Publication type:
- Article
Patient satisfaction and acceptance of their totally implanted central venous catheter: a French prospective multicenter study.
- Published in:
- Journal of Vascular Access, 2017, v. 18, n. 5, p. 390, doi. 10.5301/jva.5000744
- By:
- Publication type:
- Article
Checkpoint inhibitors in a marriage: consented or arranged?
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 12, p. 1834, doi. 10.1038/s41416-022-01820-8
- By:
- Publication type:
- Article
Checkpoint inhibitors in a marriage: consented or arranged?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 138, n. 2, p. 369, doi. 10.1007/s11060-018-2805-9
- By:
- Publication type:
- Article
Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer.
- Published in:
- Oncology, 2001, v. 60, n. 4, p. 303, doi. 10.1159/000058524
- By:
- Publication type:
- Article
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e867, doi. 10.1093/oncolo/oyad137
- By:
- Publication type:
- Article